Bo Sun - Publications

Calcification-Mediated Dual-Starvation and Immune Activation for Transarterial Chemoembolization.

Journal: International journal of nanomedicine

Published: March 27, 2026

Impact of TACE combined with targeted and immune therapy on liver function and prognosis in unresectable hepatocellular carcinoma patients: the significance of baseline albumin-bilirubin grade.

Journal: Therapeutic advances in medical oncology

Published: February 22, 2026

A radiomics-based nomogram for preoperatively predicting the invasiveness of nodular lung adenocarcinoma: a multicenter study.

Journal: Translational lung cancer research

Published: October 31, 2025

COX-2/PGE2 axis blockade with celecoxib enhances anti-PD-1 efficacy by activating natural killer cells for residual hepatocellular carcinoma after radiofrequency ablation.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 01, 2025

Combination immunotherapy targeting LAG-3, PD-1 and STING suppresses hepatocellular carcinoma as monitored by LAG-3 targeted PET imaging.

Journal: Biomarker research

Published: June 27, 2025

Radiofrequency hyperthermia enhances the antitumor efficacy of oncolytic peptide LTX-315 in liver cancer cells by activating of cGAS-STING pathway.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: June 09, 2025

Anti-CD24 Antibody Plus Liposomal Doxorubicin for the Management of Residual Cancers After Incomplete Radiofrequency Ablation.

Journal: ImmunoTargets and therapy

Published: May 29, 2025

TACE Empowers Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors in Unresectable HCC: A Multicenter Retrospective Study.

Journal: Journal of Cancer

Published: February 23, 2025

Printed Two-Dimensional Materials for Flexible Photodetectors: Materials, Processes, and Applications.

Journal: Sensors (Basel, Switzerland)

Published: January 10, 2025

Recompensation after transjugular intrahepatic portosystemic shunt reduces mortality risk: A long-term follow-up study.

Journal: European journal of radiology

Published: November 30, 2024

Oncolytic peptide LTX-315 plus an anti-CTLA-4 antibody induces a synergistic anti-cancer immune response in residual tumors after radiofrequency ablation of hepatocellular carcinoma.

Journal: Cell death & disease

Published: October 25, 2024

Lipoic Acid/Choline Ionic Liquid Enhanced Intratumoral Heat/Mass Transfer for Suppressing Thermo-Mediated Tumor Relapse and Metastasis.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: October 05, 2024